Analyst Ratings for Sinovac Biotech (SVA)

SVA Rating Summary

  |   Expand Research on SVA
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 8 / 10   Percentile Rank: 83%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/20/2014 Morgan Stanley N/A Upgrade Overweight
(Equalweight)
N/A
(N/A)
6.89
(6.47)
-6.1% Details
8/15/2013 Aegis Capital
» Updated 3/20/2014
N/A Upgrade Buy
(Hold)
7.00
(N/A)
4.57
(6.47)
41.58% Details
Like SVA Ratings? Also take a look at AZN, BNTX, MRNA, PFE

SVA Ratings News